MADRID, Jan. 28, 2026 /PRNewswire/ -- The ReDS-SAFE HF II Trial, a large multicenter investigator-initiated randomized controlled study, funded by both the Instituto de Salud Carlos III and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results